HIGHLIGHTS
- who: Kiyomi Kuba from the DepartmentMedical University have published the paper: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab, in the Journal: Scientific Reports Scientific Reports
- what: PD-L1 and ECOG PS were useful prognostic factors for virus negative HNSCC patients treated with nivolumab.
SUMMARY
The authors created a combined PD-L1 and intratumoral or stromal C D8+TIL classification, classifying patients with + both PD-L1 positive and high CD8 TIL expression (double positive) as class 1, those with PD-L1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.